UNLABELLED: Human parechoviruses (HPeVs) cause a spectrum of disease ranging from self-limiting illness to severe disease and, sometimes, death. We describe the clinical characteristics and outcomes of HPeV infection in infants. The study describes the clinical and laboratory characteristics and outcomes of infants with HPeV infection during 2008-2012, from three paediatric hospitals in London each with a paediatric intensive care unit. The infants were retrospectively identified through laboratory and patient discharge databases and diagnosed through HPeV PCR. Fifty infants were identified. Half required admission to PICU. Infants less than 3 months were more likely to require PICU (16/25: p < 0.01). Clinical signs at presentation were often indistinguishable from those of bacterial sepsis and meningitis, but inflammatory markers were nearly always (95 % of cases) within normal ranges. Brain MRI showed white matter changes in 10/12 infants. Three of 19 infants with follow-up data (16 %) had significant neurological sequelae. CONCLUSION: HPeV may cause severe disease and long-term neurological sequelae in young infants. HPeV should be considered in infants with clinical features of sepsis/meningitis with normal CSF microscopy. Prospective observational studies are warranted to better define the epidemiology of infection and thus inform future treatment trials.
UNLABELLED: Human parechoviruses (HPeVs) cause a spectrum of disease ranging from self-limiting illness to severe disease and, sometimes, death. We describe the clinical characteristics and outcomes of HPeV infection in infants. The study describes the clinical and laboratory characteristics and outcomes of infants with HPeV infection during 2008-2012, from three paediatric hospitals in London each with a paediatric intensive care unit. The infants were retrospectively identified through laboratory and patient discharge databases and diagnosed through HPeV PCR. Fifty infants were identified. Half required admission to PICU. Infants less than 3 months were more likely to require PICU (16/25: p < 0.01). Clinical signs at presentation were often indistinguishable from those of bacterial sepsis and meningitis, but inflammatory markers were nearly always (95 % of cases) within normal ranges. Brain MRI showed white matter changes in 10/12 infants. Three of 19 infants with follow-up data (16 %) had significant neurological sequelae. CONCLUSION: HPeV may cause severe disease and long-term neurological sequelae in young infants. HPeV should be considered in infants with clinical features of sepsis/meningitis with normal CSF microscopy. Prospective observational studies are warranted to better define the epidemiology of infection and thus inform future treatment trials.
Authors: M S Oberste; K Maher; M L Kennett; J J Campbell; M S Carpenter; D Schnurr; M A Pallansch Journal: J Clin Microbiol Date: 1999-12 Impact factor: 5.948
Authors: Heli Harvala; Nigel McLeish; Jasmina Kondracka; Chloe L McIntyre; E Carol McWilliam Leitch; Kate Templeton; Peter Simmonds Journal: J Med Virol Date: 2011-05 Impact factor: 2.327
Authors: L Ninove; C Tan; A Nougairede; C Zandotti; H Richet; R Charrel; X de Lamballerie Journal: Clin Microbiol Infect Date: 2009-12-10 Impact factor: 8.067
Authors: Malgorzata A Verboon-Maciolek; Floris Groenendaal; Cecil D Hahn; Jonathan Hellmann; Anton M van Loon; Guy Boivin; Linda S de Vries Journal: Ann Neurol Date: 2008-09 Impact factor: 10.422
Authors: H Harvala; I Robertson; T Chieochansin; E C McWilliam Leitch; K Templeton; P Simmonds Journal: J Infect Dis Date: 2009-06-15 Impact factor: 5.226
Authors: Sabine van der Sanden; Erwin de Bruin; Harry Vennema; Caroline Swanink; Marion Koopmans; Harrie van der Avoort Journal: J Clin Microbiol Date: 2008-07-09 Impact factor: 5.948
Authors: Katja C Wolthers; Kimberley S M Benschop; Janke Schinkel; Richard Molenkamp; Rosemarijn M Bergevoet; Ingrid J B Spijkerman; H Carlijn Kraakman; Dasja Pajkrt Journal: Clin Infect Dis Date: 2008-08-01 Impact factor: 9.079
Authors: S C M de Crom; C C Obihara; R A de Moor; E J M Veldkamp; A M van Furth; J W A Rossen Journal: J Clin Virol Date: 2013-08-21 Impact factor: 3.168
Authors: Kevin Messacar; Marc Fischer; Samuel R Dominguez; Kenneth L Tyler; Mark J Abzug Journal: Infect Dis Clin North Am Date: 2017-12-08 Impact factor: 5.982
Authors: Claire M Midgley; Mary Anne Jackson; Rangaraj Selvarangan; Patrick Franklin; Elizabeth L Holzschuh; Jennifer Lloyd; Joseph Scaletta; Anne Straily; Sheri Tubach; Ashley Willingham; W Allan Nix; M Steven Oberste; Christopher J Harrison; Charles Hunt; George Turabelidze; Susan I Gerber; John T Watson Journal: J Pediatric Infect Dis Soc Date: 2018-05-15 Impact factor: 3.164
Authors: Ted M T van Hinsbergh; Stephanie C M de Crom; Robert Lindeboom; Marceline A M van Furth; Charlie C Obihara Journal: Eur J Pediatr Date: 2019-01-14 Impact factor: 3.860
Authors: Anthony Chamings; Julian Druce; Leon Caly; Yano Yoga; Philip N Britton; Kristine K Macartney; Soren Alexandersen Journal: Sci Rep Date: 2019-06-20 Impact factor: 4.379